pharmaceutically acceptable salt or compound thereof and pharmaceutical composition and its uses and processes for improving or treating hcv infection, for inhibiting hepatitis c virus ns5b polymerase activity and hepatitis c virus replication

摘要

"Pharmaceutically acceptable compound or salt thereof and pharmaceutical composition and its uses and methods for improving or treating hcv infection, to inhibit hepatitis c virus ns5b polymerase activity and hepatitis c virus replication" summary are disclosed herein nucleotide analogs nucleotide analog synthesis processes and processes for treating disease and / or health conditions such as an hcv infection with one or more nucleotide analogs. 1/1